$5.99
0.152.57%
At close: -
$5.99
0.000.00%
After Hours: Dec 20, 4:00 PM EDT
Fennec Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fennec Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.21 | $-0.10 | -110.0 % |
Jun 2024 | 2024-08-13 | $-0.20 | $-0.03 | -566.7 % |
Mar 2024 | 2024-05-14 | $0.41 | $0.26 | 57.7 % |
Dec 2023 | 2024-03-21 | $-0.10 | $-0.02 | -400.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $6.97M | $8.82M | -20.9 % |
Jun 2024 | 2024-08-13 | $7.26M | $11.05M | -34.3 % |
Mar 2024 | 2024-05-14 | $25.38M | $18.88M | 34.4 % |
Dec 2023 | 2024-03-21 | $9.74M | $8.67M | 12.3 % |
Fennec Pharmaceuticals (FENC) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.21, which missed the estimate of $-0.10.
The Actual Revenue was $7M, which missed the estimate of $8.8M.
Browse earnings estimates, EPS, and revenue on all stocks.